Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Biochemical Engineering >  Inhibitors >  Neuronal Signaling >  5-HT Receptor agonists >  BRL 54443

BRL 54443

Basic information Safety Supplier Related

BRL 54443 Basic information

Product Name:
BRL 54443
Synonyms:
  • BRL 54443
  • 5-HYDROXY-3-(1-METHYLPIPERIDIN-4-YL)-1H-INDOLE
  • 3-(1-Methyl-4-piperidinyl)-1H-indol-5-ol
  • 3-(1-Methyl-4-piperidinyl)-1H-indol-5-ol BRL 54443
  • 3-(1-methylpiperidin-4-yl)-1H-indol-5-ol
  • 1H-Indol-5-ol, 3-(1-Methyl-4-piperidinyl)-
  • BRL 54443 HCl
  • BRL-54443;BRL54443
CAS:
57477-39-1
MF:
C14H18N2O
MW:
230.31
Product Categories:
  • Inhibitors
Mol File:
Mol File
More
Less

BRL 54443 Chemical Properties

Boiling point:
431.5±45.0 °C(Predicted)
Density 
1.196
storage temp. 
Inert atmosphere,2-8°C
solubility 
H2O: 50 mg/mL
form 
solid
pka
10.08±0.40(Predicted)
color 
white
More
Less

Safety Information

Hazard Codes 
Xi
Risk Statements 
36/37/38
Safety Statements 
26-36
WGK Germany 
3
More
Less

BRL 54443 Usage And Synthesis

Uses

BRL-53443 is a potent 5-HT and dopamine receptor agonist. Neuroresearch product.

Definition

ChEBI: 3-(1-methyl-4-piperidinyl)-1H-indol-5-ol is a member of hydroxyindoles.

Biological Activity

A potent 5-ht 1E/1F receptor agonist (pEC 50 values are 8.5 and 8.6 respectively). Displays > 30-fold selectivity over other 5-HT and dopamine receptors (pK i values are 8.7. 8.9, 7.2, 6.9, 7.2, 5.9, 7.0, 6.5, < 6, < 6, 6.3 and 6.2 for human 5-HT 1E , 1F , 1A , 1B , 1D , 2A , 2B , 2C , 4 , 7 , D 2 and D 3 receptors respectively). Induces 5-HT 2A receptor-mediated mouse aortic contraction in vitro (pEC 50 = 6.52). Active in vivo .

Synthesis

111963-87-2

57477-39-1

1. 5-methoxy-3-(1-methyl-4-piperidinyl)indole (2.30 g, 9.4 mmol) was dissolved in 30 mL of 30% hydrobromic acid acetic acid solution. 2. The reaction mixture was placed in a sealed tube and heated at 105 °C for 72 hours. 3. Upon completion of the reaction, it was cooled to room temperature and concentrated under vacuum to remove the solvent. 4. the concentrated residue was dissolved in water and the pH was adjusted to about 13 with 5N aqueous sodium hydroxide solution. 5. Vacuum concentration is performed again and the residue is purified by silica gel column chromatography using a methanol/dichloromethane solution of 20% 2M ammonia as eluent. 6. The target fraction was collected, concentrated under vacuum and the residue was dissolved in methanol. 7. Dowex? 50X8-200 ion exchange resin (25 g) was added and stirred overnight at room temperature. 8. Filter the mixture and wash the resin sequentially with water and methanol. 9. Mix the resin with 100 mL of 2 M ammonia in methanol, stir overnight and filter. 10. The filtrate was concentrated in vacuum to give 1.84 g (85% yield) of 3-(1-methylpiperidin-4-yl)-1H-indol-5-ol, which could be used in subsequent steps without further purification. 11. Elemental analysis results: For C13H17N3O, calculated values: C, 67.53; H, 7.36; N, 18.18. measured values: C, 67.24; H, 7.37; N, 18.38.

in vivo

Reduction of flinching was considered as antinociception. Ipsilateral, but not contralateral, peripheral administration of BRL54443 (5-HT(1E/1F); 3-300 microg/paw) significantly reduced formalin-induced flinching in rats[3].

IC 50

5-HT1E Receptor: 1.1 nM (Ki); 5-HT1F Receptor: 0.7 nM (Ki); 5-HT1A Receptor: 63 nM (Ki); 5-HT1B Receptor: 126 nM (Ki); 5-HT1D Receptor: 63 nM (Ki); 5-HT2A Receptor: 1259 nM (Ki); 5-HT2B Receptor: 100 nM (Ki); 5-HT2C Receptor: 316 nM (Ki); 5-HT6 Receptor: >10,000 nM (Ki); 5-HT7 Receptor: >10,000 nM (Ki)

storage

+4°C (desiccate)

References

1. a.m. brown, k. avenell, t j. young et al. brl 54443, a potent agonist with selectivity for human cloned 5-ht1e and 5-ht1f receptors. 1998. br.j.pharmacol. 123 233p.2. s. lightowler, t. stean, n. upton et al. effect of brl 54443 (3-(1-methylpiperidin-4-yl)-1h-indol-5-ol), a 5-ht1e/1f receptor agonist, on general behaviour and maximal electroshock seizure threshold in the rat. 1998. br.j.pharmacol. 123 237p.3. mckune cm, watts sw. characterization of the serotonin receptor mediating contraction in the mouse thoracic aorta and signal pathway coupling. j pharmacol exp ther. 2001 apr;297(1):88-95.4. janssen p, tack j, sifrim d et al. influence of 5-ht1 receptor agonists on feline stomach relaxation. eur j pharmacol. 2004 may 25;492(2-3):259-67.

BRL 54443Supplier

Shanghai Boyle Chemical Co., Ltd.
Tel
Email
sales@boylechem.com
3B Pharmachem (Wuhan) International Co.,Ltd.
Tel
821-50328103-801 18930552037
Email
3bsc@sina.com
Nanjing Chemlin Chemical Co., Ltd
Tel
025-83697070
Email
info@chemlin.com.cn
BOC Sciences
Tel
1-631-485-4226; 16314854226
Email
info@bocsci.com
Dalian Meilun Biotech Co., Ltd.
Tel
0411-62910999 13889544652
Email
sales@meilune.com